logo

For the Inventor, By the Inventor

Pavillons-sous-Bois, France

Roger Deraedt

USPTO Granted Patents = 40

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 440(Granted Patents)


Location History:

  • Les Pavillons-sous-Bois, FR (1980 - 1982)
  • Pavillons S/S Bois, FR (1985)
  • Pavilons-sous-Bois, FR (1990 - 1991)
  • Pavillons-sous-Bois, FR (1976 - 1993)

Company Filing History:

goldMedal39 out of 854 
 
Roussel Uclaf
 patents
silverMedal1 out of 5 
 
Roussel-ulcaf
 patents

Years Active: 1976-1993

Loading Chart...
40 patents (USPTO):Explore Patents
1. 5182381 - Intermediates for 3-keto-19-nor-.DELTA..sup.4,9 -steroids (1993-01-26),
2. 5064822 - Novel 3-keto-19-nor-.DELTA..sup.4,9 -steroids (1991-11-12),
3. 5043332 - Novel 11.beta.-substituted -19-nor-steriods (1991-08-27),
4. 4978657 - Novel 11.beta.-substituted-19-nor-steroids (1990-12-18),
5. 4880803 - Method of inducing immunostimulating activity (1989-11-14),
6. 4760070 - Analgesic compositions and method (1988-07-26),
7. 4634696 - Novel 11 beta-substituted-19-nor-steroids (1987-01-06),
8. 4614736 - Novel anti-inflammatory treatment (1986-09-30),
9. 4567198 - Ethanethioates and mercaptoamides and use thereof as analgesic and (1986-01-28),
10. 4547493 - Novel 11.beta.-substituted-19-nor-steroids (1985-10-15),
11. 4540686 - 3-Keto-19-nor-.DELTA..sup.4,9 -steroids (1985-09-10),
12. 4522816 - Analgesic treatment and compositions (1985-06-11),
13. 4519946 - Steroids (1985-05-28),
14. 4518775 - Benzoxazine-4-one intermediates (1985-05-21),
15. 4515787 - Steroids (1985-05-07),

Title: The Innovative Contributions of Roger Deraedt in Pharmaceuticals

Introduction: Roger Deraedt, a prominent inventor based in Pavillons-sous-Bois, France, is renowned for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio comprising 40 patents, he has dedicated his career to the development of novel compounds with therapeutic applications.

Latest Patents: Among his latest innovations are groundbreaking patents related to intermediates for 3-keto-19-nor-Δ4,9-steroids. These patents detail novel structures and pharmaceutical-grade salts featuring exceptional antiglucocorticoidal activity, showcasing Deraedt's advanced understanding of medicinal chemistry. The compounds he has designed include various alkyl and aromatic substitutions that enhance their efficacy and safety.

Career Highlights: Throughout his career, Deraedt has worked with reputable organizations, including Roussel Uclaf, where he played a vital role in pharmaceutical research and development. His expertise in steroid chemistry has led to advancements that benefit therapeutic practices and patient care in the medical field.

Collaborations: Roger Deraedt has collaborated with esteemed colleagues, including Jean G. Teutsch and André Allais. These collaborations have fostered innovation and contributed to the successful development of new pharmaceutical products, amplifying the impact of their collective research efforts.

Conclusion: Roger Deraedt's work exemplifies the essence of innovation within the pharmaceutical sector. His extensive patent portfolio and collaborative spirit reflect a commitment to enhancing therapeutic options and improving patient outcomes. Through his continued efforts, Deraedt remains a valuable asset to the field of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…